The Roles of microRNAs in Cancer Multidrug Resistance

Lucia Pavlíková1, Mário Šereš1, Albert Breier1,2

  • 1Institute of Molecular Physiology and Genetics, Centre of Bioscience, Slovak Academy of Sciences, Dúbravská Cesta 9, 84005 Bratislava, Slovakia.

Cancers
|February 25, 2022
PubMed

Insights

MicroRNAs (miRNAs) may play a key role in how cancer cells develop multidrug resistance (MDR). Understanding miRNA interactions could lead to new cancer therapies targeting MDR mechanisms.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cancer chemotherapy can lead to multidrug resistance (MDR).
  • MDR involves complex molecular mechanisms like ABC transporters, drug-metabolizing enzymes, apoptosis, cell cycle, and DNA repair.
  • The interplay between these MDR mechanisms is not fully understood.

Purpose of the Study:

  • To explore the potential role of microRNAs (miRNAs) in the molecular mechanisms underlying MDR.
  • To analyze miRNAs as potential effectors or therapeutic targets in overcoming MDR.

Main Methods:

  • Literature review and analysis of existing research on miRNA function and MDR.
  • Investigating the post-transcriptional regulatory role of miRNAs via mRNA binding and degradation.
  • Examining the connection between miRNA expression and MDR-associated molecular pathways.

Main Results:

  • MicroRNAs regulate post-transcriptional processes, impacting protein synthesis.
  • miRNAs can bind to target messenger RNAs (mRNAs), inhibiting translation or promoting degradation.
  • This regulatory function positions miRNAs as critical players in the complex network of MDR mechanisms.

Conclusions:

  • MicroRNAs are implicated in the development and interplay of MDR mechanisms in cancer.
  • miRNAs represent promising candidates for novel therapeutic strategies against MDR.
  • Further research into miRNA-mediated regulation is crucial for advancing cancer treatment.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.2K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K